Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5880402 | 0.90 | TRPM8 (0.50) | NPSR1KMT2AMEN1ALDH1A1NPC1 | |
| SCHEMBL5121109 | 0.89 | ALDH1A1 (0.48) | NPSR1KMT2AMEN1ALDH1A1NPC1 | |
| SCHEMBL12914594 | 0.86 | NPSR1 (0.61) | NPSR1KMT2AMEN1ALDH1A1NPC1 | |
| SCHEMBL11726572 | 0.83 | NPSR1 (0.46) | NPSR1KMT2AMEN1ALDH1A1NPC1 | |
| SCHEMBL11176462 | 0.82 | NPSR1 (0.57) | NPSR1KMT2AMEN1ALDH1A1NPC1 | |
| SCHEMBL10890513 | 0.82 | LMNA (0.45) | NPSR1KMT2AMEN1ALDH1A1HTT | |
| SCHEMBL28977221 | 0.80 | LMNA (0.48) | NPSR1KMT2AMEN1ALDH1A1NPC1 | |
| SCHEMBL137254 | 0.80 | LMNA (0.59) | NPSR1KMT2AMEN1ALDH1A1NPC1 | |
| SCHEMBL11036446 | 0.80 | SMN1; SMN2 (0.49) | NPSR1KMT2AMEN1ALDH1A1NPC1 | |
| SCHEMBL11509507 | 0.80 | SMN1; SMN2 (0.44) | NPSR1KMT2AMEN1ALDH1A1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4638538-A1 | LIQUID RHEOLOGY CONTROL AGENT | BYK-Chemie GmbH (DE) | 2025-10-29 | — | — | EP | claimed |
| CN-119194640-A | Nanometer composite nitrocellulose containing stabilizer and preparation method thereof | 南京理工大学 | 2024-12-27 | — | — | CN | claimed |
| US-20240239721-A1 | Resin Cured Binary Explosive | VK Integrated Systems, Inc. (US) | 2024-07-18 | — | — | US | claimed |
| WO-2024133435-A1 | LIQUID RHEOLOGY CONTROL AGENT | BYK-CHEMIE GMBH (DE) | 2024-06-27 | — | — | WO | claimed |
| CN-118047652-A | Double-base propellant and its preparing process | 江西威源民爆器材有限责任公司 | 2024-05-17 | — | — | CN | claimed |
| CN-114437376-B | Preparation method of nitrocotton for nail shooting medicine | 北方化学工业股份有限公司 | 2023-09-26 | — | — | CN | claimed |
| CN-116376062-A | Nitrocellulose microsphere with narrow particle size distribution and preparation method thereof | 北方化学工业股份有限公司 | 2023-07-04 | — | — | CN | claimed |
| CN-114437376-A | Preparation method of nitrocotton for nailing medicine | 北方化学工业股份有限公司 | 2022-05-06 | — | — | CN | claimed |
| CN-113840815-A | Low smoke pyrotechnic composition | 内斯特F/X公司 | 2021-12-24 | — | — | CN | claimed |
| EP-3462876-B1 | PLANT TREATMENT COMPOSITION | CRODA INT PLC (GB) | 2021-07-28 | — | — | EP | claimed |
| EP-2367828-A1 | Process for the preparation of tetrazine derivatives | Reliance Life Sciences Pvt., Ltd. (IN) | 2011-09-28 | — | — | EP | claimed |
| US-20110230658-A1 | PROCESS FOR THE PREPARATION OF TETRAZINE DERIVATIVES | RELIANCE LIFE SCIENCES PVT. LTD. (IN) | 2011-09-22 | — | — | US | claimed |
| WO-2010058430-A1 | PROCESS FOR THE PREPARATION OF TETRAZINE DERIVATIVES | RELIANCE LIFE SCIENCES PVT. LTD. (IN) | 2010-05-27 | — | — | WO | claimed |
| US-20090223611-A1 | Black Powder Substitutes for Small Caliber Firearms | GENERAL DYNAMICS ORDNANCE AND TACTICAL SYSTEMS- CANADA VALLEYFIELD INC. (CA) | 2009-09-10 | — | — | US | claimed |
| EP-1768644-B1 | LIGHT PROTECTING-EFFECTIVE COSMETIC OR DERMATOLOGICAL PREPARATIONS | CIBA HOLDING INC (CH) | 2009-02-18 | — | — | EP | claimed |
| US-20070225496-A1 | PROCESS FOR PREPARING TEMOZOLOMIDE | DR. REDDY'S LABORATORIES, INC. | 2007-09-27 | — | — | US | claimed |
| WO-2007090278-A1 | BLACK POWDER SUBSTITUTES FOR SMALL CALIBER FIREARMS | GENERAL DYNAMICS ORDNANCE AND TACTICAL SYSTEMS - CANADA VALLEYFIELD INC. (CA) | 2007-08-16 | — | — | WO | claimed |
| US-6860208-B2 | Nitrocellulose gas generating material for a vehicle occupant protection apparatus | TRW INC. (US) | 2005-03-01 | — | — | US | claimed |
| US-20020084010-A1 | Nitrocellulose gas generating material for a vehicle occupant protection apparatus | TRW INC. | 2002-07-04 | — | — | US | claimed |
| US-4797419-A | AGING RESISTANCE | WARNER-LAMBERT COMPANY (US) | 1989-01-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070225496-A1 | PROCESS FOR PREPARING TEMOZOLOMIDE | MGMT, TET2, FIP1L1 | NPSR1 3996/4885KMT2A 325/4885MEN1 21/4885 |
| US-20110230658-A1 | PROCESS FOR THE PREPARATION OF TETRAZINE DERIVATIVES | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HRH4, C1R | NPSR1 100/4885KMT2A 4370/4885MEN1 1647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.